分子病理学在诊断学中的应用与研究
Research and Application of Molecular Pathology in Diagnostics
DOI: 10.12677/ACRVM.2019.71002, PDF,   
作者: 韩建冬*, 王红康, 王建民, 董佳轩, 张 杰, 周 浩, 杨 庭, 额尔敦:内蒙古医科大学,内蒙古 呼和浩特
关键词: 病理学诊断癌症 Pathology Diagnosis Cancer
摘要: 分子生物学技术的进步为分子诊断提供了新的思路,与传统的培养及表型鉴定相比,分子诊断技术大大缩短了诊断所需时间,同时提高了敏感性和特异性,且操作简便、易于重复。分子诊断方法大多在培养的基础上进行病原真菌分子鉴定,也有报道某些分子生物学技术可直接从液体培养瓶,甚至临床样本中进行病原检测。随着分子生物学理论和技术的不断发展,目前基于核酸和蛋白质的分子诊断技术已经开始逐步应用于临床,分子水平的诊断技术需要的时间短、特异性和敏感性高,在一定程度上克服了传统诊断方法的缺陷,可以实现对病原菌的早期、特异诊断,改善患者预后、提高患者生存率。核酸等温扩增技术能在一定温度下完成对DNA或RNA的扩增,与传统PCR方法相比,核酸等温扩增技术对仪器的要求极大地简化,恒温水浴即可完成反应,时间也大大地缩短,能满足实现操作简单、快速诊断的需求。环介导等温扩增技术针对基因序列的六个独立片段设计两对引物,实现对核酸片段的特异性扩增。
Abstract: Advances in molecular biology technology have provided new ideas for molecular diagnosis. Compared with traditional culture and phenotypic identification, molecular diagnostic technology has greatly shortened the time required for diagnosis, while improving sensitivity and specificity, and is easy to operate and easy to repeat. Molecular diagnostic methods mostly perform molecular identification of pathogenic fungi on the basis of culture. It is also reported that some molecular biology techniques can directly detect pathogens from liquid culture bottles and even clinical samples. With the continuous development of molecular biology theory and technology, molecular diagnostic techniques based on nucleic acids and proteins have begun to be gradually applied in clinical practice. The diagnostic techniques at the molecular level require short time, high specificity and sensitivity, and overcome to some extent. The defects of traditional diagnostic methods can achieve early and specific diagnosis of pathogenic bacteria, improve patient prognosis and improve patient survival rate. The nucleic acid isothermal amplification technology can complete the amplification of DNA or RNA at a certain temperature. Compared with the traditional PCR method, the nucleic acid isothermal amplification technology greatly simplifies the requirements of the instrument, and the constant temperature water bath can complete the reaction, and the time is also greatly shortened; it can meet the needs of simple and fast diagnosis. Loop-mediated isothermal amplification techniques design two pairs of primers for six independent fragments of the gene sequence to achieve specific amplification of the nucleic acid fragments.
文章引用:韩建冬, 王红康, 王建民, 董佳轩, 张杰, 周浩, 杨庭, 额尔敦. 分子病理学在诊断学中的应用与研究[J]. 亚洲心脑血管病例研究, 2019, 7(1): 8-15. https://doi.org/10.12677/ACRVM.2019.71002

参考文献

[1] Armstrong, S.A., Staunton, J.E., Silverman, L.B., Pieters, R., den Boer, M.L., Minden, M.D., Sallan, S.E., Lander, E.S., Golub, T.R. and Korsmeyer, S.J. (2002) MLL Translocations Specify a Distinct Gene Expression Profile That Distin-guishes a Unique Leukemia. Nature Genetics, 30, 41-47. [Google Scholar] [CrossRef] [PubMed]
[2] Baggerly, K.A., Morris, J.S., Edmonson, S.R. and Coombes, K.R. (2005) Signal in Noise: Evaluating Reported Reproducibility of Serum Proteomic Tests for Ovarian Cancer. Journal of the National Cancer Institute, 97, 307-309. [Google Scholar] [CrossRef] [PubMed]
[3] Baylin, S.B., Esteller, M., Rountree, M.R., Bachman, K.E., Schuebel, K. and Herman, J.G. (2001) Aberrant Patterns of DNA Methylation Chromatin Formation and Gene Expression in Cancer. Human Molecular Genetics, 10, 687-692. [Google Scholar] [CrossRef] [PubMed]
[4] Bertucci, F., Nasser, V., Granjeaud, S., Eisinger, F., Adelaide, J., Tagett, R., Loriod, B., Giaconia, A., Benziane, A., Devilard, E., Jacquemier, J., Viens, P., Nguyen, C., Birnbaum, D. and Houlgatte, R. (2002) Gene Expression Profiles of Poor-Prognosis Primary Breast Cancer Correlate with Survival. Human Molecular Genetics, 11, 863-872. [Google Scholar] [CrossRef] [PubMed]
[5] Bertucci, F., Viens, P., Hingamp, P., Nasser, V., Houlgatte, R. and Birnbaum, D. (2003) Breast Cancer Revisited Using DNA Arraybased Gene Expression Profiling. International Journal of Cancer, 103, 565-571. [Google Scholar] [CrossRef] [PubMed]
[6] Brazma, A. and Vilo, J. (2000) Gene Expression Data Analysis. FEBS Letters, 480, 17-24. [Google Scholar] [CrossRef
[7] Cowherd, S.M., Espina, V.A., Petricoin III, E.F. and Liotta, L.A. (2004) Proteomic Analysis of Human Breast Cancer Tissue with Laser Capture Microdissection and Reverse-Phase Protein Microarrays. Clinical Breast Cancer, 5, 385-392. [Google Scholar] [CrossRef
[8] Dancey, J. and Sausville, E.A. (2003) Issues and Progress with Protein Kinase Inhibitors for Cancer Treatment. Nature Reviews Drug Discovery, 2, 296-313. [Google Scholar] [CrossRef] [PubMed]
[9] Dhanasekaran, S.M., Barrette, T.R., Ghosh, D., Shah, R., Varambally, S., Kurachi, K., Pienta, K.J., Rubin, M.A. and Chinnaiyan, A.M. (2001) Delineation of Prognostic Biomarkers in Prostate Cancer. Nature, 412, 822-826. [Google Scholar] [CrossRef] [PubMed]
[10] Diamandis, E.P. (2004) Analysis of Serum Proteomic Patterns for Early Cancer Diagnosis: Drawing Attention to Potential Problems. Journal of the National Cancer Institute, 96, 353-356. [Google Scholar] [CrossRef] [PubMed]
[11] Diamandis, E.P. and van der Merwe, D.E. (2005) Plasma Protein Profiling by Mass Spectrometry for Cancer Diagnosis: Opportunities and Limitations. Clinical Cancer Research, 11, 963-965.
[12] Eisen, M.B., Spellman, P.T., Brown, P.O. and Botstein, D. (1998) Cluster Analysis and Display of Ge-nome-Wide Expression Patterns. Proceedings of the National Academy of Sciences, 95, 14863-14868. [Google Scholar] [CrossRef] [PubMed]
[13] Eschrich, S., Yang, I., Bloom, G., Kwong, K.Y., Boulware, D., Cantor, A., Coppola, D., Kruhoffer, M., Aaltonen, L., Orntoft, T.F., Quackenbush, J. and Yeatman, T.J. (2005) Molec-ular Staging for Survival Prediction of Colorectal Cancer Patients. Journal of Clinical Oncology, 23, 3526-3535. [Google Scholar] [CrossRef
[14] Goldmann, T., Flohr, A.M., Murua, E.H., Gerstmayer, B., Janssen, U., Bosio, A., Loeschke, S., Vollmer, E. and Bullerdiek, J. (2004) The HOPE-Technique Permits Northern Blot and Microarray Analyses in Paraffin-Embedded Tissues. Pathology—Research and Practice, 200, 511-515. [Google Scholar] [CrossRef] [PubMed]
[15] Hofmann, W.K., de Vos, S., Elashoff, D., Gschaidmeier, H., Hoelzer, D., Koeffler, H.P. and Ottmann, O.G. (2002) Relation between Resistance of Philadelph-ia-Chromosome-Positive Acute Lymphoblastic Leukaemia to the Tyrosine Kinase Inhibitor STI571 and Gene Expression Profiles: A Gene-Expression Study. The Lancet, 359, 481-486. [Google Scholar] [CrossRef
[16] Huang, E., Cheng, S.H., Dressman, H., Pittman, J., Tsou, M.H., Horng, C.F., Bild, A., Iversen, E.S., Liao, M., Chen, C.M., West, M., Nevins, J.R. and Huang, A.T. (2003) Gene Expression Predictors of Breast Cancer Outcomes. The Lancet, 361, 1590-1596. [Google Scholar] [CrossRef
[17] Hudelist, G., Pacher-Zavisin, M., Singer, C.F., Holper, T., Kubista, E., Schreiber, M., Manavi, M., Bilban, M. and Czerwenka, K. (2004) Use of High-Throughput Protein Array for Profiling of Differentially Expressed Proteins in Normal and Malignant Breast Tissue. Breast Cancer Research and Treatment, 86, 281-291. [Google Scholar] [CrossRef
[18] Jones, P.A. and Baylin, S.B. (2002) The Fundamental Role of Epigenetic Events in Cancer. Nature Reviews Genetics, 3, 415-428. [Google Scholar] [CrossRef] [PubMed]
[19] Khan, J., Simon, R., Bittner, M., Chen, Y., Leighton, S.B., Pohida, T., Smith, P.D., Jiang, Y., Gooden, G.C., Trent, J.M. and Meltzer, P.S. (1998) Gene Expression Profiling of Alveolar Rhabdomyosarcoma with cDNA Microarrays. Cancer Research, 58, 5009-5013.
[20] Khan, J., Wei, J.S., Ringner, M., Saal, L.H., Ladanyi, M., Westermann, F., Berthold, F., Schwab, M., Antonescu, C.R., Peterson, C. and Meltzer, P.S. (2001) Classification and Diagnostic Prediction of Cancers Using Gene Expression Profiling and Artificial Neural Networks. Nature Medicine, 7, 673-679. [Google Scholar] [CrossRef] [PubMed]
[21] Kusnezow, W., Jacob, A., Walijew, A., Diehl, F. and Hoheisel, J.D. (2003) Antibody Microarrays: An Evaluation of Production Parameters. Proteomics, 3, 254-264. [Google Scholar] [CrossRef] [PubMed]